搜索临床试验以:Early Stage Breast cancer
总计100767个结果
-
TriHealth Inc.TriHealth Hatton Research Institute; Bethesda North Hospital Foundation终止早期乳腺癌 | 乳腺肿瘤 | 乳腺肿瘤美国
-
University of Michigan终止
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Breast Cancer Research Foundation完全的
-
University of California, San FranciscoNational Cancer Institute (NCI)完全的
-
University of Utah完全的
-
Ottawa Hospital Research Institute完全的
-
University of Michigan Rogel Cancer Center终止
-
German Breast GroupRoche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor Pharma完全的炎性乳腺癌 | HER2阳性乳腺癌 | 管状乳腺癌 II 期 | 粘液性乳腺癌 II 期 | 乳腺癌女性 NOS | 浸润性导管癌 | 管状乳腺癌 III 期德国
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Cianna Medical, Inc.终止I期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIC期乳腺癌 | 小叶乳腺癌原位癌 | 雌激素受体阴性 | 雌激素受体阳性 | HER2/Neu 阴性 | 孕激素受体阳性 | 乳腺导管原位癌 | 粘液性乳腺癌 | 管状乳腺癌 | 浸润性导管癌,未另行说明 | 浸润性筛状乳腺癌 | 乳头状乳腺癌美国
-
Midwestern Regional Medical Center撤销
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital完全的
-
Heidelberg UniversityVerein für Krebsforschung, Arlesheim, Swizzerland; Weleda AG, D-73525 Schwäbisch Gmünd完全的
-
University College, LondonEuropean Union完全的
-
Peregrine Pharmaceuticals撤销乳腺癌 | 三阴性乳腺癌 | 三阴性乳腺肿瘤 | 三阴性乳腺癌 | 三阴性乳腺肿瘤 | ER 阴性 PR 阴性 HER2 阴性乳腺肿瘤 | ER 阴性 PR 阴性 HER2 阴性乳腺癌
-
Memorial Sloan Kettering Cancer CenterAmgen完全的
-
Duke UniversityNational Cancer Institute (NCI)完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University未知
-
University of North Carolina, Chapel HillNational Cancer Institute (NCI); Duke University完全的
-
National University of Singapore完全的
-
ETOP IBCSG Partners Foundation完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital 和其他合作者完全的
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); Cancer and Leukemia Group B; Breast Cancer Trials, Australia...完全的
-
Baptist Health South Florida完全的